BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 4444954)

  • 1. [Letter: Meningoencephalic cryptococcosis. Presence of filamentous forms. Acquired resistance to 5 fluorocytosine and amphotericin B therapy].
    Cadoz M; Micoud M; Pasquier B; Massot C; Goullier A
    Nouv Presse Med; 1974 Oct; 3(33):2108-9. PubMed ID: 4444954
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-fluorocytosine: a replacement for amphotericin B in the treatment of candida and cryptococcus neoformans infections?
    Pankey GA; Lockwood WR; Montalvo JM
    J La State Med Soc; 1970 Dec; 122(12):365-9. PubMed ID: 5492591
    [No Abstract]   [Full Text] [Related]  

  • 3. Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
    Halkin H; Ravid M; Zulman J; Reichert N
    Isr J Med Sci; 1974 Sep; 10(9):1148-52. PubMed ID: 4611967
    [No Abstract]   [Full Text] [Related]  

  • 4. [Cryptococcus neoformans meningoencephalitis].
    Langberg CW; Barkve H; Tjørstad K
    Tidsskr Nor Laegeforen; 1984 May; 104(14):968-70. PubMed ID: 6087494
    [No Abstract]   [Full Text] [Related]  

  • 5. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
    Fass RJ; Perkins RL
    Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162
    [No Abstract]   [Full Text] [Related]  

  • 6. Letter: Amphotericin B and 5-fluorocytosine.
    Medoff G; Kobayashi GS
    J Infect Dis; 1975 Oct; 132(4):489-90. PubMed ID: 1102615
    [No Abstract]   [Full Text] [Related]  

  • 7. [On meningoencephalitis caused by Cryptococcus neoformans. Diagnostic and therapeutic study].
    Arcuri F; Robert L; Cavallero F
    Arch Maragliano Patol Clin; 1971; 27(2):99-121. PubMed ID: 4401355
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro sensitivity to amphotericin B of Cryptococcus neoformans isolated in Thailand.
    Gaew-Im M; Thasnakorn P
    J Med Assoc Thai; 1971 Jan; 54(6):405-9. PubMed ID: 5171413
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-fluorocytosine in the treatment of cryptococcal meningitis.
    McGill PE; Sequeira R; Jindani A; Nguli ET; Forrester AT; Fulton WF
    East Afr Med J; 1969 Dec; 46(12):663-8. PubMed ID: 5378176
    [No Abstract]   [Full Text] [Related]  

  • 10. [On a case of primary cryptococcal encephalo-meningitis treated with amphotericin B].
    Sixtová E; Lasovská J; Doutlík S; Dvorsky K
    G Mal Infett Parassit; 1966 Nov; 18(11):791-4. PubMed ID: 5987235
    [No Abstract]   [Full Text] [Related]  

  • 11. [Meningoencephalitis torulosa unsuccessfully treated by amphothericin B].
    Pavlík E; Vagunda S; Valihrach J
    Vnitr Lek; 1974 Nov; 20(11):1121-5. PubMed ID: 4439667
    [No Abstract]   [Full Text] [Related]  

  • 12. Cryptococcal meningoencephalitis and 5-fluorocytosine.
    Beine JP; Lontie M; Vandepitte J
    Br Med J; 1971 Apr; 2(5753):107. PubMed ID: 4927910
    [No Abstract]   [Full Text] [Related]  

  • 13. Systemic humicolus cryptococcosis.
    Shinde SM; Vanarse KS; Pandit AN
    Indian Pediatr; 2004 Nov; 41(11):1162-4. PubMed ID: 15591670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cryptococcus neoformans infection. Illustrated by a case of meningitis].
    Odegaard A; Steinbakk M; Stavem P
    Tidsskr Nor Laegeforen; 1983 Oct; 103(28):1930-2. PubMed ID: 6648930
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine.
    Shadomy S; Shadomy HJ; McCay JA; Utz JP
    Antimicrob Agents Chemother (Bethesda); 1968; 8():452-60. PubMed ID: 5735392
    [No Abstract]   [Full Text] [Related]  

  • 16. Acute parkinsonism in Cryptococcus gattii meningoencephalitis: extensive lesions in basal ganglia.
    Pedroso JL; Barsottini OG
    Mov Disord; 2012 Sep; 27(11):1372. PubMed ID: 23001937
    [No Abstract]   [Full Text] [Related]  

  • 17. Success with amphotericin B and 5-fluorocytosine in treating cerebral cryptococcoma accompanying cryptococcal meningitis.
    Bayardelle P; Giard N; Maltais R; Delorme J; Brazeau M
    Can Med Assoc J; 1982 Oct; 127(8):732-3. PubMed ID: 7139489
    [No Abstract]   [Full Text] [Related]  

  • 18. Primary cutaneous cryptococcosis successfully treated with outpatient amphotericin B and 5-fluorocytosine.
    Butler WP; Kaufer GI
    NITA; 1985; 8(4):295-7. PubMed ID: 3852083
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased susceptibility of Cryptococcus neoformans to amphotericin B in the presence of steroids.
    Mohr JA; Tatem BA; Long H; Muchmore HG; Felton FG
    Sabouraudia; 1973 Jul; 11(2):140-2. PubMed ID: 4584201
    [No Abstract]   [Full Text] [Related]  

  • 20. Editorial: Cryptococcosis and 5-fluorocytosine.
    Zylstra W
    Aust N Z J Med; 1974 Jun; 4(3):296-9. PubMed ID: 4531906
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.